诊断和治疗Igan:类固醇,Budesonide,或者可能是两者兼而有之?
Christodoulos Keskinis1, Eleni Moysidou2, Michalis Christodoulou2
1Department of Nephrology, Papageorgiou General Hospital, 56429 Thessaloniki, Greece.
Diagnostics (Basel, Switzerland)
|March 13, 2024
概括
IgA病 (IgAN) 是一种具有有限的诊断生物标志物和次优治疗方法的病. 向释放布埃索尼德提供了一种新的方法,比传统类固醇副作用更少.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- IgA脏病 (IgAN) 是最常见的原发性血球炎,其特点是脏中的IgA沉积物.
- 当前的理解包括:
- 四次击中假设的四次击中假设
- 但其他机制,比如B细胞原始化,也与此有关.
- 由于生物标志物的准确性不足,诊断依赖于脏活检.
研究的目的:
- 审查IgAN治疗中皮质类固醇和向释放布德索尼德的益处和不良事件.
- 探索IGAN的组合治疗的潜力.
主要方法:
- 对Igan治疗现有文献的系统审查.
- 对类固醇和布德索尼德的疗效和安全数据的分析.
- 基于组织学活性对治疗结果的评估.
主要成果:
- 系统性皮质类固醇减少蛋白尿,但具有显著的不良事件和复发率.
- 向释放布德索尼德具有局部作用,改善功能和减少蛋白尿.
- 该审查强调了需要超越当前护理标准的新型治疗策略的需要.
结论:
- 向释放布埃索尼德是一种潜在的更安全和更有效的替代品或传统IgAN疗法的辅助.
- 对组合疗法的进一步研究可能会使被选中的具有活跃疾病的Igan患者受益.
- 优化Igan治疗需要解决有效性和长期安全性.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
118
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
118
Inflammatory Bowel Disease IV: Pharmacological Management
127
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
127
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
246
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
246
Drugs for Treatment of Ulcerative Colitis in IBD
141
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331


